Covidien Acquires CNS Therapeutics for $100,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4f5ba081-416d-47f5-8fae-955ebcbb6268&Preview=1 - Date
9/25/2012 - Company Name
CNS Therapeutics - Mailing Address
332 Minnesota Street Saint Paul, MN 55101 - Company Description
CNS Therapeutics develops and brings to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. Gablofen (baclofen injection) marks first breakthrough for CNS Therapeutics. - Website
http://www.gablofen.com - Transaction Type
M&A - Transaction Amount
$100,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Additional financial terms of the transaction were not disclosed by the parties.
